
Sora Neuroscience’s Cirrus Brain Mapping Software Receives FDA Approval
Sora Neuroscience’s Cirrus brain mapping software has received FDA approval, aiding neurosurgeons in surgical planning. π§ β
Discover the newest research about AI innovations in π§ Neuroscience.

Sora Neuroscience’s Cirrus brain mapping software has received FDA approval, aiding neurosurgeons in surgical planning. π§ β

AI identifies FJMU1887, a Gal-3 inhibitor, enhancing cognition and reducing neuroinflammation in Alzheimer’s models. π§ π

AI revolutionizes drug discovery for neurological diseases, enhancing molecule identification and treatment potential. π€π

AI-Driven H-SYSTEM Achieves 94.87% Accuracy in Hypertensive Intracerebral Hemorrhage Diagnosis π§ π

AI in healthcare boosts efficiency, especially for neurological disorders. New models enhance cost-effectiveness and access. ππ§

Enhanced brain tumor detection via MRI using Berkeley wavelet transformation shows improved accuracy and efficiency. π§ π

Amphetamine may lower Parkinson’s disease risk by 41% over 6 years, according to recent AI-driven research. π§ π

Chipiron raises $17 million for portable MRI development, aiming to enhance accessibility in local care centers and clinics. π₯π°

AI and machine learning are improving stroke treatment, aiming to reduce disability and enhance patient outcomes. π§ π‘
New AI tool, MindGlide, assesses treatment effectiveness for multiple sclerosis using MRI scans. Promising advancements in patient care. π§ π‘